Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2024
Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group
Alexander W Wyatt, Saskia Litiere, Francois-Clément Bidard, et al.
Endocrine-Related Cancer
|
February 18, 2014
p27 variant and corticotropinoma susceptibility: a genetic and in vitro study
Tomoko Sekiya, Marcello D Bronstein, Katiuscia Benfini, et al.
Nature Medicine
|
September 13, 2022
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF<sup>V600E</sup> metastatic colorectal cancer
Elena Elez, Javier Ros, Jose Fernández, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 25, 2012
Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS
Nishant Agrawal, Yuchen Jiao, Mark Sausen, et al.
JAMA
|
December 16, 2010
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas
Li Yao, Francesca Schiavi, Alberto Cascon, et al.
European Journal of Endocrinology
|
June 13, 2014
Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations
Viviane C Longuini, Delmar M Lourenço, Tomoko Sekiya, et al.
Endocrine-Related Cancer
|
June 27, 2017
The penetrance of MEN2 pheochromocytoma is not only determined by <i>RET</i> mutations
Frederic Castinetti, Ana Luiza Maia, Mariola Peczkowska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2025
Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy
Elena Garralda, Charles Abbott, Alma Calahorro, et al.
Human Mutation
|
October 28, 2010
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10
Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, et al.
The Lancet. Oncology
|
April 22, 2014
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study
Frederic Castinetti, Xiao-Ping Qi, Martin K Walz, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 13, 2024
Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group
Alexander W Wyatt, Saskia Litiere, Francois-Clément Bidard, et al.
Endocrine-Related Cancer
|
February 18, 2014
p27 variant and corticotropinoma susceptibility: a genetic and in vitro study
Tomoko Sekiya, Marcello D Bronstein, Katiuscia Benfini, et al.
Nature Medicine
|
September 13, 2022
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF<sup>V600E</sup> metastatic colorectal cancer
Elena Elez, Javier Ros, Jose Fernández, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 25, 2012
Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS
Nishant Agrawal, Yuchen Jiao, Mark Sausen, et al.
JAMA
|
December 16, 2010
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas
Li Yao, Francesca Schiavi, Alberto Cascon, et al.
European Journal of Endocrinology
|
June 13, 2014
Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations
Viviane C Longuini, Delmar M Lourenço, Tomoko Sekiya, et al.
Endocrine-Related Cancer
|
June 27, 2017
The penetrance of MEN2 pheochromocytoma is not only determined by <i>RET</i> mutations
Frederic Castinetti, Ana Luiza Maia, Mariola Peczkowska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2025
Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy
Elena Garralda, Charles Abbott, Alma Calahorro, et al.
Human Mutation
|
October 28, 2010
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10
Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, et al.
The Lancet. Oncology
|
April 22, 2014
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study
Frederic Castinetti, Xiao-Ping Qi, Martin K Walz, et al.
Page
of 7